Biohaven BHVN Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Biohaven in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biohaven's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biohaven's cash & equivalents?
- Biohaven (BHVN) reported cash & equivalents of $277.11M in Q1 2026.
- How has Biohaven's cash & equivalents changed year-over-year?
- Biohaven's cash & equivalents increased by 169.8% year-over-year, from $102.69M to $277.11M.
- What is the long-term trend for Biohaven's cash & equivalents?
- Over 5 years (2020 to 2025), Biohaven's cash & equivalents has grown at a 22.8% compound annual growth rate (CAGR), from $83.51M to $232.78M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.